Pancreatic Cancer Research

ResearcherCity of HopeActive in the last 2 years

Zeljka Jutric

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1792-4376; OpenAlex author ID A5033974891. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. Co-author DOI 10.1016/j.jcmgh.2026.101872↗
  2. Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach. Co-author DOI 10.1002/cam4.71447↗
  3. Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection. Co-author DOI 10.1002/jso.27121↗
  4. Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma. Last author DOI 10.1007/s13304-022-01404-4↗
  5. Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarcinoma: a multi-institutional analysis. First author DOI 10.1016/j.hpb.2019.12.012↗
  6. Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0238380↗
  7. New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer. Co-author PMID 28620900↗
  8. A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pa… Co-author DOI 10.1186/s40425-016-0149-6↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David K. Imagawa · 3 shared papers, 2023–2026 · strength 0.69
  2. Ronald Wolf · 3 shared papers, 2016–2023 · strength 0.45
  3. Jennifer Brooke Valerin · 1 shared paper, 2025 · strength 0.25
  4. Farshid Dayyani · 1 shared paper, 2025 · strength 0.25
  5. Steven Neema Seyedin · 1 shared paper, 2025 · strength 0.25
  6. Garrett K. Harada · 1 shared paper, 2025 · strength 0.25
  7. David S. Hong · 1 shared paper, 2025 · strength 0.25
  8. Paul Hansen · 3 shared papers, 2016–2020 · strength 0.24
  9. Oliver Gene McDonald · 1 shared paper, 2026 · strength 0.23
  10. Nikki K. Lytle · 1 shared paper, 2026 · strength 0.23
  11. Christopher J. Halbrook · 1 shared paper, 2026 · strength 0.23
  12. Nina G. Steele · 1 shared paper, 2026 · strength 0.23
  13. Austin D. Silva · 1 shared paper, 2026 · strength 0.23
  14. Rima Singh · 1 shared paper, 2026 · strength 0.23
  15. Ian M. Loveless · 1 shared paper, 2026 · strength 0.23
  16. Mohammed Aldakkak · 1 shared paper, 2026 · strength 0.23
  17. Alica K. Michels · 1 shared paper, 2026 · strength 0.23
  18. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.23
  19. Oscar Hernandez Dominguez · 1 shared paper, 2023 · strength 0.22
  20. Melanie R. Goldfarb · 1 shared paper, 2023 · strength 0.18
  21. Anthony Joseph Scholer · 1 shared paper, 2023 · strength 0.18
  22. Laleh Golkar Melstrom · 1 shared paper, 2017 · strength 0.15
  23. Michael James Gough · 2 shared papers, 2016–2020 · strength 0.14
  24. Marka R. Crittenden · 2 shared papers, 2016–2020 · strength 0.14
  25. Kristina Hoot Young · 2 shared papers, 2016–2020 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.